Pharmacodynamic Modeling of Vecuronium‐induced Twitch Depression: Rapid Plasma‐Effect Site Equilibration Explains Faster Onset at Resistant Laryngeal Muscles than at the Adductor Pollicis
暂无分享,去创建一个
[1] C. Meistelman,et al. Mivacurium Neuromuscular Block at the Adductor Muscles of the Larynx and Adductor Pollicis in Humans , 1996, Anesthesiology.
[2] J H Proost,et al. Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans , 1995, Clinical pharmacology and therapeutics.
[3] Ronald D. Miller,et al. Onset and Duration of Rocuronium and Succinylcholine at the Adductor Pollicis and Laryngeal Adductor Muscles in Anesthetized Humans , 1994, Anesthesiology.
[4] R. Miller,et al. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers. , 1994, The Journal of pharmacology and experimental therapeutics.
[5] C. Meistelman,et al. Comparison of Twitch Depression of the Adductor Pollicis and the Respiratory Muscles Pharmacodynamic Modeling without Plasma Concentrations , 1994, Anesthesiology.
[6] F. Donati,et al. Importance of Early Blood Sampling on Vecuronium Pharmacokinetic and Pharmacodynamic Parameters , 1993, Clinical pharmacokinetics.
[7] C. Meistelman,et al. Neuromuscular Effects of Succinylcholine on the Vocal Cords and Adductor Pollicis Muscles , 1991, Anesthesia and analgesia.
[8] C. Meistelman,et al. A method to measure elicited contraction of laryngeal adductor muscles during anesthesia. , 1991, Anesthesiology.
[9] C. Meistelman,et al. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. , 1991, Anesthesiology.
[10] C. Meistelman,et al. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. , 1990, Anesthesiology.
[11] L B Sheiner,et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models , 1986, Clinical pharmacology and therapeutics.
[12] D. Newton,et al. Rate of onset of good intubating conditions, respiratory depression and hand muscle paralysis after vecuronium. , 1984, British journal of anaesthesia.
[13] Lewis B. Sheiner,et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine , 1979 .
[14] R. Miller,et al. Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. , 1988, Journal of chromatography.